Evidence map›Paper›PMID 34682780›Full record

ReviewJournal of clinical medicine2021

COPD Diagnosis: Time for Disruption.

Emiel F M Wouters, Marie K Breyer, Robab Breyer-Kohansal, Sylvia Hartl

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Diagnostic Potential of Oscillometry: A Population-based Approach.American journal of respiratory and critical care medicine · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Emiel F M WoutersLudwig Boltzmann Institute for Lung Health, 1140 Vienna, Austria.
Marie K BreyerLudwig Boltzmann Institute for Lung Health, 1140 Vienna, Austria.
Robab Breyer-KohansalLudwig Boltzmann Institute for Lung Health, 1140 Vienna, Austria.
Sylvia HartlLudwig Boltzmann Institute for Lung Health, 1140 Vienna, Austria.
Ludwig Boltzmann Institute for Digital Health and PreventionLudwig Boltzmann Institute for Lung Vascular Research · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Articulating a satisfactory definition of a disease is surprisingly difficult. Despite the alarming individual, societal and economic burden of chronic obstructive pulmonary disease (COPD), diagnosis is still largely based on a physiologically dominated disease conception, with spirometrically determined airflow limitation as a cardinal feature of the disease. The diagnostic inaccuracy and insensitivity of this physiological disease definition is reviewed considering scientific developments of imaging of the respiratory system in particular. Disease must be approached as a fluid concept in response to new scientific and medical discoveries, but labelling as well as mislabelling someone as diseased, will have enormous individual, social and financial implications. Nosology of COPD urgently needs to dynamically integrate more sensitive diagnostic procedures to detect the breadth of abnormalities early in the disease process. Integration of broader information for the identification of abnormalities in the respiratory system is a cornerstone for research models of underlying pathomechanisms to create a breakthrough in research.

Indexed as

airflow limitationCOPDearly diseasetaxonomy

Identifiers

PMID34682780
PMCPMC8539379
OpenAlexW3205779077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.